Loading...

China Oncology

30 April 2021, Volume 31 Issue 4
Cover and contents

2021 Issue 4 Cover

Abstract ( 177) PDF (2578KB) ( 155 )

Contents of Issue 4, 2021

2021, 31 (4): 2-.

Abstract ( 16) PDF (268KB) ( 33 )

Specialists’ Commentary

FUSCC criteria for the management of targeted drug-induced interstitial lung disease in solid tumors

ZHANG Jian , SHEN Weina , JI Dongmei , WANG Leiping , GONG Chengcheng , HU Xichun

2021, 31 (4): 241-249. doi: 10.19401/j.cnki.1007-3639.2021.04.001

Abstract ( 238) PDF (2822KB) ( 648 )

Leading research progress and prospect of gynecological oncology in 2020

ZHU Jun, WU Xiaohua

2021, 31 (4): 250-256. doi: 10.19401/j.cnki.1007-3639.2021.04.002

Abstract ( 302) PDF (1226KB) ( 909 )

Current status and prospects of migration of radioactive  125 I seed implanted in malignant tumor 

ZHU Junjun, GE Naijian, YANG Yefa

2021, 31 (4): 257-262. doi: 10.19401/j.cnki.1007-3639.2021.04.003

Abstract ( 127) PDF (1314KB) ( 423 )

Article

NDRG2 increases bladder cancer cell sensitivity to cisplatin by inhibiting Bcl-2 expression

LI Ruixiao , TANG Qisheng , MA Shanjin , ZHANG Bo , LI Xuelian , ZHANG Zhiming

2021, 31 (4): 263-267. doi: 10.19401/j.cnki.1007-3639.2021.04.004

Abstract ( 138) PDF (2129KB) ( 450 )

Protein kinase Cβ Ⅱ promotes invasion of hepatocellular carcinoma by modulating autocrine of IL-6

LIU Min , CHEN Tianliang , GUO Juan , YI Xue , GAO Hongquan , WU Jiacui , WANG Yuxiao

2021, 31 (4): 268-276. doi: 10.19401/j.cnki.1007-3639.2021.04.005

Abstract ( 90) PDF (3745KB) ( 412 )

Mechanism of inhibition of epithelial-to-mesenchymal transition by phosphorylated H2AX in lung cancer cells

QIAO Tingting , GE Shujing , LUO Yuan , LU Chengrong , DUAN Lianning

2021, 31 (4): 277-284. doi: 10.19401/j.cnki.1007-3639.2021.04.006

Abstract ( 91) PDF (3244KB) ( 411 )

Expression of LRP8 in gastric cancer and its significance in tumorigenesis

LIU Bin , ZHENG Pengyuan , MI Yang , REN Feifei , GAO Shuang , LIU Chuan , LI Fazhan

2021, 31 (4): 285-293. doi: 10.19401/j.cnki.1007-3639.2021.04.007

Abstract ( 142) PDF (4149KB) ( 494 )

A novel strategy of regorafenib in combination with TAS102 against hepatocellular carcinoma

ZHANG Jun , DONG Yuhua , YANG Ye , ZHANG Mengqi , HE Chang

2021, 31 (4): 294-301. doi: 10.19401/j.cnki.1007-3639.2021.04.008

Abstract ( 104) PDF (3074KB) ( 117 )

Clinical application of fine needle puncture Diff-Quik staining for the differentiation and protection of parathyroid glands in thyroid carcinoma surgery 

YUAN Hao , JIANG Xiaofei , YOU Qinghua , ZHU Hongbo , YE Huiying , WU Wen , QIAN Fengyuan , ZHONG Ming , LI Yongping

2021, 31 (4): 302-307. doi: 10.19401/j.cnki.1007-3639.2021.04.009

Abstract ( 113) PDF (1309KB) ( 96 )

Effect of PD-L1 expression on the efficacy of pemetrexed-based chemotherapy in patients with advanced lung adenocarcinoma and its mechanism

SHI Maolin , BAI Yudi , WANG Chao , LI Siqi , ZHOU Daijun , PENG Jingjing , SUN Feifan , LI Dong , ZHANG Tao

2021, 31 (4): 308-316. doi: 10.19401/j.cnki.1007-3639.2021.04.010

Abstract ( 126) PDF (2503KB) ( 161 )

Factors influencing postoperative hypercoagulability of free flap reconstruction for head and neck tumor

LU Ming, HONG Yuming, ZHENG Chaohui, CHEN Xiaofang, LIANG Zhenyuan

2021, 31 (4): 317-322. doi: 10.19401/j.cnki.1007-3639.2021.04.011

Abstract ( 107) PDF (1161KB) ( 107 )

Prognostic nomogram for elderly breast cancer patients with 1-2 positive nodes who underwent mastectomy and different axillary surgeries: a SEER-based study

ZENG Feng , LI Dan , SHAO Xinxin , ZHANG Nengying , CHEN Xinghan , CHENG Xiaoming

2021, 31 (4): 323-329. doi: 10.19401/j.cnki.1007-3639.2021.04.012

Abstract ( 107) PDF (2165KB) ( 141 )

Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases

CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin

2021, 31 (4): 330-334. doi: 10.19401/j.cnki.1007-3639.2021.04.013

Abstract ( 115) PDF (1304KB) ( 159 )

The control of lung cancer relating to quitting active smoking and secondary smoking: a case-control study of lung cancer in Taiyuan

MU Lina , SU Jia , YU Shunzhang , NIU Rungui , HAN Xiaoyou , LIU Li , SHI Jianping , ZHANG Zuofeng

2021, 31 (4): 335-343. doi: 10.19401/j.cnki.1007-3639.2021.04.014

Abstract ( 90) PDF (3664KB) ( 122 )

Review

The progress and prospect of homologous recombination deficiency detection in clinical diagnosis and treatment of cancer

YU Li , SHEN Minna , JIANG Huiqin , WANG Beili , GUO Wei

2021, 31 (4): 344-349. doi: 10.19401/j.cnki.1007-3639.2021.04.015

Abstract ( 150) PDF (1246KB) ( 260 )

Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer

LI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang

2021, 31 (4): 350-360. doi: 10.19401/j.cnki.1007-3639.2021.04.016

Abstract ( 137) PDF (1959KB) ( 203 )

中国癌症杂志
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • SCOPUS
  • Chemical Abstracts
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHEN Zhenzhou

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat